Pfizer, BioNTech request expanded emergency use of COVID-19 vaccine in adolescents

A doctor prepares a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine in the eastern German town of Weisswasser, Germany, April 9, 2021. REUTERS/Michaela Rehle

(Corrects syntax in paragraph 1)

(Reuters) – Pfizer Inc and its German partner BioNtech SE on Friday said they have requested U.S. regulatory agencies to expand the emergency use of their COVID-19 vaccine in adolescents aged 12 to 15.

In March, the drugmakers said the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year olds in a clinical trial.

The Pfizer/BioNTech two-shot vaccine is already authorized for use in people as young as 16.

(This story refiles to correct syntax in paragraph 1)

Source: Read Full Article